Numerous treatments are being developed to target the genes causing the more than 100 epilepsies that have been linked to a single gene mutation.
Artificial Intelligence
For the best possible care, ultra-rare illnesses need both sophisticated genetic tests and diverse clinical competence.
A new artificial intelligence model called SyntheMol is developed by Stanford Medicine researchers. It generates formulas that chemists may use to synthesize pharmaceuticals in the lab.
Researchers discover that they can identify sepsis before symptoms appear by using a special AI system that keeps track of several patient factors, such as vital signs and test findings.
Researchers demonstrated that these substances could eradicate methicillin-resistant Staphylococcus aureus.
Google is on their way to developing an ARM-Augmented Reality Microscope in a joint venture with the U.S. Department of Defense. Currently, Google has developed a prototype. They incorporate AI with the microscope system to classify cancer cells using visual indicators.
